IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 416

India’s cumulative vaccination coverage crosses 179 Crore landmark milestone. More than 18 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 179 Crore landmark milestone (1,79,09,28,099) today. More than 18 lakh (18,24,967Vaccine Doses have been administered till 7 pm today. More than 2.07 Crore (2,07,35,818) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10402197
2nd Dose 9977321
Precaution Dose 4256605
FLWs 1st Dose 18410616
2nd Dose 17463033
Precaution Dose 6403967
Age Group 15-18 years 1st Dose 55481332
  2nd Dose 31434778
Age Group 18-44 years 1st Dose 552710170
2nd Dose 450630396
Age Group 45-59 years 1st Dose 202425853
2nd Dose 181622958
Over 60 years 1st Dose 126525204
2nd Dose 113108423
Precaution Dose 10075246
Cumulative 1st dose administered 965955372
Cumulative 2nd dose administered 804236909
Precaution Dose 20735818
Total 1790928099

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 7th March, 2022 (416th Day)
HCWs 1st Dose 63
2nd Dose 1230
Precaution Dose 10066
FLWs 1st Dose 114
2nd Dose 2246
Precaution Dose 14331
Age Group 15-18 years 1st Dose 73673
  2nd Dose 464347
Age Group 18-44 years 1st Dose 105232
2nd Dose 774262
Age Group 45-59 years 1st Dose 16629
2nd Dose 175309
Over 60 years 1st Dose 10651
2nd Dose 110640
Precaution Dose 66174
Cumulative 1st dose administered 206362
Cumulative 2nd dose administered 1528034
Precaution Dose 90571
Total 1824967

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker